Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cognition Therapeutics, Inc

0.4474
+0.03247.81%
Post-market: 0.44740.00000.00%19:58 EDT
Volume:370.67K
Turnover:161.14K
Market Cap:18.59M
PE:-0.47
High:0.4484
Open:0.4300
Low:0.4210
Close:0.4150
Loading ...

B. Riley upgrades Cognition Therapeutics to Buy on Lewy bodies data

TIPRANKS
·
19 Dec 2024

Cognition Therapeutics upgraded to Buy from Neutral at B. Riley

TIPRANKS
·
19 Dec 2024

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires Live
·
19 Dec 2024

Cognition Therapeutics Shares More Than Double as Dementia Drug Meets Main Goal in Mid-Stage Trial

THOMSON REUTERS
·
18 Dec 2024

Cognition Therapeutics Says Study of Drug to Treat Lewy Body Dementia Meets Primary Endpoint; Shares Jump

MT Newswires Live
·
18 Dec 2024

BUZZ-Cognition Therapeutics rises as dementia drug meets main goal in mid-stage trial

Reuters
·
18 Dec 2024

Cognition Therapeutics Shares up 62.7% Premarket After Dementia Drug Meets Main Goal in Mid-Stage Trial

THOMSON REUTERS
·
18 Dec 2024

Cognition Therapeutics announces results in Phase 2 study of CT1812

TIPRANKS
·
18 Dec 2024

Cognition Therapeutics Inc: Expediting Plans to Advance Ct1812 Into Late-Stage Trials

THOMSON REUTERS
·
18 Dec 2024

Cognition Therapeutics Inc - Study Met Primary Endpoint of Safety and Tolerability

THOMSON REUTERS
·
18 Dec 2024

Cognition Therapeutics Announces Positive Results in Phase 2 Study of Ct1812 in Dementia With Lewy Bodies

THOMSON REUTERS
·
18 Dec 2024

Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies

GlobeNewswire
·
18 Dec 2024

We're A Little Worried About Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Rate

Simply Wall St.
·
13 Dec 2024

Cognition Therapeutics (CGTX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks
·
28 Nov 2024

Positive Clinical Trial Developments and Financial Position Drive Buy Rating for Cognition Therapeutics

TIPRANKS
·
27 Nov 2024

BRIEF-Cognition Therapeutics Announces All Participants Have Completed Their Final Visits

Reuters
·
26 Nov 2024